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A549 human pulmonary epithelial cells 
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PAR Protease activated receptor 
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RNAi Ribonucleic acid interference 
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There have been valuable researches regarding health problems at seafood processing 
areas and with seafood industry workers. In the past few years airway symptoms have 
been reported in the seafood industry workers. This study was carried out on the 
background that airway symptoms are generated in king crab industry workers.  
 
In these in vitro studies, we focus on moricrase (enzyme mixture from hapatopancreas 
of king crab) as an activator of inflammatory responses in airway cells. King crab 
industry workers are highly exposed to bioaerosoles containing enzymes as well as 
other bioactive agents. These bioaerosoles are produced during industrial processing of 
king crab. Taking under consideration that serine proteases, such as trypsin, are 
stimulator of interlukin-8 (IL-8). We investigate the role of protease activated receptor 2 
(PAR-2) in the inflammation of human pulmonary epithelial cells (A549).  PAR-2 is 
considered as an important factor under the pathological situations in human airways. 
Human airway epithelial cells were exposed to moricrase and we observed that 
moricrase induces stimulation of IL-8.  
 
In the dose-response experiments moricrase has shown stimulation of IL-8 in A549 
cells. In six hours incubation with different concentrations of moricrase, A549 cells 
have shown maximum levels of IL-8 with 0.03325 µg/ml of moricrase. In our time 
response data, the cells have shown a gradual increase in IL-8 production and a 







Finally, it has been found that after the stimulation of A549 cells with moricrase, the 
release of IL-8 is mediated through the activation of PAR-2 by using specific small 
interfering RNAs (siRNAs). Although the release of IL-8 after stimulation with 
moricrase was lower than the IL-8 release after stimulation with spotted mackerel 
trypsin. Our data confirms the involvement of PAR-2 as by using PAR-2 siRNAs, the 
production of IL-8 was reduced 85.5%. With respect to our findings we can suggest that 
moricrase, via activation of PAR-2, might produce inflammation or influence the 





























King crab industry workers are highly exposed to bioaerosoles. These tiny water 
droplets may contain some proteases that may have effects on the human respiratory 
system. King crab industry workers have shown airway symptoms. Our study was 
aimed to find out whether moricrase (a mixture of collageno and fibrinolytic proteinases 
from Paralithodes camchatica (king crab) hepatopancreas) stimulates the inflammatory 
mediator (IL-8) in human pulmonary epithelial (A549) cells and if so, to characterize 
the time and dose dependency of such stimulation. Moreover, to find out if moricrase 






















1.1. Human Airway.  
 
Lungs are the organs of respiration in humans. Many foreign substances are inhaled 
daily, but the lungs have mechanisms that usually prevent people from making 
unwanted immune responses to these materials. Sometimes, however, immune 
responses are generated to these substances, resulting in allergic responses and airway 
symptoms (Hammad et al., 2009).  
 
Breathing in certain dusts, gases, fumes and vapors within the workplace can cause 
various airway symptoms from upper as well as lower respiratory tract, like shortness of 
breath, sneezing, running nose, etc. 
 
Airway symptoms have been reported in the seafood industries (Gaddie et al., 1980). 
The employees in the seafood industry are exposed to a variety of factors that may 
cause airway symptoms (Bang et al., 2005). Water is used extensively in many 
processes of the seafood industry and the production area contains large amount of 
moisture. Production machines produce wet aerosols that spread in the breathing zone 
of the workers. Workers of seafood industry having increased prevalence of airway 
symptoms compared to control population as the bioaerosols may contain biological 
materials. The moist environment may also facilitate the growth of microorganisms.  
 
1.1.1. Types of respiratory cells 
 
More than 40 different types of respiratory tract cells have been identified. The five 
major cell populations of the lung include type 1 and type 2 alveolar epithelial cells, 
capillary endothelial cells, alveolar macrophages and interstitial cells. These cells form 
 10
the basic structure underlying gas exchange in the lung. In lung cells our interest is 
directed to the epithelial cells as these are the cells which can be exposed to the 
xenobiotics directly. 
 
1.1.2. Alveolar type two epithelial cells 
 
These are cuboidal cells that cover 7% of alveolar surface and represent 16% of total 
cell population. Type two cells are able to differentiate into type 1 cell and replace 
damaged cells.(Dart, 2004) 
Epithelial cells protect underlying tissue from mechanical injury, harmful chemicals and 
pathogens and excessive water loss. Sensory stimuli are detected by specialized 
epithelial cells. Specialized epithelial tissue containing sensory nerve endings are found 
in the airway. Simple epithelium promotes the diffusion of gases, liquids and nutrients. 
Because they form such a thin lining, they are ideal for the diffusion of gases (e.g. walls 
of capillaries and lungs). [http://en.wikipedia.org/wiki/Epithelium] 
 
1.2. Airway epithelial cells and our study 
 
Inhalation of bioaerosols can affect the airway epithelium and can cause inflammation 
in lower and upper respiratory tract by the production and secretion of cytokines. 
Previous research explored that in the seafood industry, production workers inhale 
aerosols containing biological material (Bang et al., 2005; Jeebhay et al., 2005). The 
origin of biological materials can either be a raw material itself or the environmental 
microbiological organisms. 
 
Processing of crab, shrimps, and clam is associated with increased risk of occupational 
asthma (Gaddie et al., 1980; Desjardins et al., 1995; Jeebhay et al., 2001). Production 
workers in the salmon industry has shown enhanced occurrence of symptoms from the 
airways (Douglas et al., 1995; Bang et al., 2005). Allergic diseases associated with 
 11
occupational exposure to crab is well characterized, whereas for other seafood agents 
the evidence is somewhat limited (Jeebhay et al., 2001). 
 
1.2.1. Human alveolar epithelial cells (A549 cells) 
 
Human alveolar type 2 epithelial cells collected in 1972 from 58 years old man infected 
with lung carcinoma. A549 cells showed adherent growth and they are extensively used 
in several experiments for the investigations of biological system. 
 
1.3. Protease-activated receptors (PARs) 
 
Protease-activated receptors (PARs) are a subfamily of G protein-coupled receptors that 
are activated by cleavage of certain part of their N terminal extra cellular domain. They 
are expressed throughout the whole body including lungs (Macfarlane et al., 2001). 
 
Proteases are widely distributed in biological materials, although good methods for 
quantification in bioaerosol samples are not yet available. Recent  reports indicate the 
importance of serine proteases for the induction of cytokine production following 
exposure to molds (Borger et al., 1999; Kauffman et al., 2000), cockroach extracts 
(Bhat et al., 2003) and mites (King et al., 1998; Tomee et al., 1998). This protease 
induced cytokine productions are mainly mediated by activation of protease-activated 
receptor (PAR)-2 (Sun et al., 2001; Asokananthan et al., 2002b; Page et al., 2003; Hong 
et al., 2004). 
 
PAR activity is modulated by airway proteases of endogenous and exogenous origin, 
which can either activate or disable the receptors. The regulation of PAR activity by 
proteases is important under pathological conditions when the activity of proteases is  
increased (Sokolova and Reiser, 2007). Moreover, various inflammatory mediators, 
such as cytokines, growth factors, or prostanoids, alter the PAR expression level. 
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Elevated PAR levels are observed in various lung disorders, including asthma (Knight 
et al., 2001). 
  
1.3.1. Classification of Protease activated receptors (PARs) 
 
PARs are classified into four known types PAR1, PAR2, PAR3, and PAR4. These 
receptors are members of the seven transmembrane G-protein-coupled receptor super 
family. 
 
1.3.2. Activation of PARs 
 
PAR1-PAR4 has an activation site that is recognized by specific proteases, and its 
cleavage results in formation of a new N-terminus, which serves as a tethered ligand 
(Macfarlane et al., 2001). Fig. 1.1 is a schematic diagram for PARs activation 
mechanism by proteolysis. The receptor (depicted on the left side) undergoes 
transformed by cleavage through a specific protease. The proteolytic activity generates 
the new N-terminus. Binding of this new tethered ligand to the extracellular loop 2, as 
shown on the right side, causes receptor activation and triggering of cellular responses. 
Some of the activating proteases, which are active in the respiratory tract, are also 
indicated besides the cleavage site in Fig. 1.1. 
 
Previously activation of PARs was ascribed exclusively  to the family of serine 
proteases, like thrombin and trypsin but recent findings have shown the activation of 
PARs from matrix metalloproteinase (MMP), namely MMP-1 (Boire et al., 2005; 







Fig. 1.1 Mechanism of activation of protease activated receptors. The receptor consist 
of an extracellular N-terminus (N), 7 transmembrane domains and an intracellular C-
terminus (C). Proteases of exogenous origin (from airborne allergens) and endogenous 
origin (belonging to the coagulation system, released from inflammatory cells, 
extrapancreatic trypsin) cleave the N-terminal part of PARs and unmask the tethered 
ligand (shown as a black box). Binding of this tethered ligand to the second 
extracellular loop of the receptor results in receptor activation and induction of cell 
signaling. Modified from.  (Sokolova and Reiser, 2007). 
 
1.3.4. PAR-2 in human airways 
 
The PARs are present in different tissues and cells in the mammalian body. PAR-1 and 
PAR-2 are present in epithelial and smooth muscle cells of  respiratory system (Cocks 
and Moffatt, 2001; Ossovskaya and Bunnett, 2004). PAR-2 is  considered as pro-
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inflammatory in the respiratory system, and in asthmatic patients have found an up 
regulation of PAR-2 in the respiratory epithelium(Knight et al., 2001). 
 
In human alveolar epithelial cells (A549), activation of PAR-2 induces enhancement of 
expression and release of important inflammatory mediators such as IL-6, IL-8, and 
prostaglandin E2 (Asokananthan et al., 2002a). matrix-metalloproteinase-9 (MMP-9) 
(Vliagoftis et al., 2000) and granulocyte macrophage-colony stimulating factor (GM-
CSF) (Vliagoftis et al., 2001). 
 
There is still conflicting data concerning the role of PAR-2 in airway inflammatory 
response. Protective anti-inflammatory effects of PAR-2 activation in mice were 
documented (Moffatt et al., 2002). 
 
1.3.5. PAR-2 Activators. 
 
All PARs activate with a similar mechanism. Lung epithelium is a source of potent 
PAR-2 activators.Epithelial derived trypsin and human airway trypsin-like protease 
(HAT) are endogenous activators of PAR-2 (Ostrowska et al., 2007). Other endogenous 
proteases which possess the ability to modulate PAR activity originate from 
hematopoietic cells (mast cell tryptase, neutrophil elastase, cathepsin G and proteinase 
3). Tryptase is released from activated mast cells in airways during allergen challenge.  
In the lung epithelial cells, PAR-2 can also be activated by exogenous proteinases 
including house dust mite allergens (Kawabata and Kawao, 2005). Serine proteases like 
trypsin and chymotrysin are known agonists for PAR-2. 
  
1.3.6. Role of PAR-2 in airway inflammation 
 
PAR-2 is present in the smooth muscle cells and, upon activation, can cause 
broncoconstriction via activation in smooth muscles. In the human alveolar epithelial 
cells , activation of PAR-2 induces  release of several mediators of inflammation. 
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PAR-2 also mediate smooth muscle proliferation, which in addition to the pro-
inflammatory roles of PAR-2 in the epithelium, may contribute to development of 
airway symptoms. PAR-2 can cause inflammation upon activation in human airways as 
shown in Fig.1.2. PAR-2 may also contribute to a protective effect by the activation of 
prostanoid (PGE2) causing a prostanoid-dependent smooth muscle relaxation. The 




Fig.1.2. Possible roles of PAR-2 in the respiratory system. Tryptase from mast cells, 
factors VIIa and Xa from blood vessels, and possibly trypsin from the adjacent 
epithelial cells activate PAR-2 in the epithelium, which in turn causes release of various 
inflammatory mediators and promotes inflammation. Crab proteases like trypsin and 
chymotrypsin could be exogenous agonists for PAR-2. F VIIa and F Xa, coagulation 
factors VIIa and Xa, respectively; PGE2, prostaglandin E2; EP2, prostaglandin EP2 
receptor. Modified from (Kawabata and Kawao, 2005) 
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1.3.7. Role of PAR-2 in allergy 
 
The role of PAR-2 in adaptive immune responses is less known than in innate 
inflammatory responses. Studies suggest a protective (D'Agostino et al., 2007) as well 
as exacerbating (Schmidlin et al., 2002; Ebeling et al., 2005) effect of PAR-2 
stimulation to allergic challenges. Stimulation of PAR-2 results in super oxide 





Fig.1.3. Interaction of allergen proteases with epithelial cells. Cell damage and 
cytokine release are shown concomitantly with the proposed effects on the inflammatory 
response and facilitation of the immune response. APC, Antigen-presenting cells; MCP-
1, monocyte chemotactic protein-1. Modified from (Kauffman et al., 2000) 
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Epithelial cells have shown great importance in innate immunity (Bals and Hiemstra, 
2004). They can also recognize microorganisms by surface receptors (Bals and 
Hiemstra, 2004). Crab antigen tropomyocin may be present in bioaerosols, produced at 
the production area in crab industry. Furthermore crab proteases like trypsin and 
chymotrypsin also play an important role in the innate inflammatory responses. 
Activation of PAR-2 induces cytokines (Tomee et al., 1998) known to be important in 
inflammatory responses.  
 
1.3.8. Desensitization of PAR-2 
 
PAR-2 desensitization is initiated by the phosphorylation of C-terminal (Kumar et al., 
2007) that may lead to,  
• receptor shutoff;  
• further phosphorylation and receptor internalization;  
• sequestration; 
• proteolytic degradation of the receptor protein as well as the tethered ligand. 
     The mechanism of receptor internalization following phosphorylation is still unclear. 
 
1.3.9. Disarming of PAR-2 
 
Disarming is a phenomenon by which any receptor loose it’s function due to “loss of 
arm”. An example of disarming is, disarming of PAR-2 by cathepsin G and elastase.  
During lung inflammation, airspaces are covered by neutrophiles that release elastase 
and cathepsin G (serine proteases). These proteases do not activate PAR-2 but rather 
disarm the receptor by cleaving it on disarming cleavage sites and prevents the 






1.4. IL-8 as an indicator of inflammatory 
responses. 
 
Lungs epithelium is the first tissue to contact with inhaled pathogens and shows the 
response by releasing inflammatory mediators and cytokines. Respiratory epithelial 
cells can synthesize and secrete many  proinflammatory cytokines such as IL-8, IL-1, 
IL-6, GM-CSF (Cromwell et al., 1992) which controls the cell behavior in 
physiological and pathological conditions. 
 
During recent years serine proteases got more importance in the understanding of 
airway disease. Particularly the importance of tryptase (Krishna et al., 2001)  in the 
development of asthma. Serine proteases perform a role in the induction of cytokine 
hypersecreation in airways (Uehara et al., 2003) and production of IL-8, as increased 
levels of IL-8 were found in asthma (Nocker et al., 1996). 
 
The A549 cells have shown higher levels of IL-8 after stimulation with serine proteases. 
The increased IL-8 levels have been observed previously in A549 cells via activation of 
protease activated receptors. Interleukin (IL)-8 is a marker of inflammatory response 
and in our studies IL-8 was used as an indicator of inflammatory response. 
 
1.5. The seafood proteases. 
1.5.1. Seafood 
 
Seafood is processed by skilled workers in different workplaces. They include 
fishermen, workers in processing plants where seafood is heated, prepared, etc. Seafood 
can cause IgE-mediated allergic reactions when they are aerosolized (Malo and Cartier, 
1993). Various organ or systemic manifestations can be seen in sensitized workers. 
During processing and cleaning procedures in seafood industry, organic particles are 
emitted into the air and workers display increased prevalence of airway symptoms 
(Douglas et al., 1995; Bang et al., 2005). Previous studies shows that in airway 
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epithelial cells, salmon trypsin is a potent activator of PAR-2 and PAR-2 activation is 
coupled to increased production of IL-8 (Larsen et al., 2008).  
 
1.5.2. Serine protease 
 
Serine proteases are the catalytic enzymes in which one of the amino acids at the active 
site is serine. They are widely distributed in the human body as well as in fish and found 
in both single-cell and complex organisms.  
 
Serine proteases can be classified into clans that share structural similarities 
(homology). The major clans found in humans, include the chymotrypsin, trypsin and 
elastase.In the history of evolution, serine proteases were basically digestive enzymes. 
In mammals, they evolved by gene duplication to perform functions in blood clotting, 
the immune system, and inflammation. 
 
Serine proteases, such as mast cell tryptase, trypsin-like enzymes, and certain allergens 
are important in the pathogenesis of asthma. These proteases can activate PAR–2. PAR-
2 and PAR-4 are activated primarily by trypsin-like proteases (Macfarlane et al., 2001). 
Trypsin, tryptase, and coagulation factors VIIa and Xa are considered possible 
endogenous activators for PAR-2 in the airway (Ossovskaya and Bunnett, 2004). 
 
1.5.3. Trypsin and trypsin-like proteases 
 
Trypsin is a member of serine proteases used to digest food and is found in the digestive 
tract. It is also released by immune cells to help to destroy bacteria. Trypsin and trypsin 
like proteases can activate protease activated receptors in the airways and cause 




1.5.4. Mechanism of serine protease 
 
Proteases or proteinases are enzymes that catalyze the hydrolysis of peptidic bonds. In 
serine proteases the catalysis is based on nucleophilic attack of the targeted peptidic 
bond. In many cases the nucleophilic property of  serine proteases is improved by the 
presence of a histidine, held in a "proton acceptor state" by an aspartate. Aligned side 





Moricrase is generated from the hepatopancreas of kamachatka crab paralithodes 
camachatica (Rudenskaya et al., 2000) and is a mixture of proteolytic enzymes 
including serine proteases, like trypsin. Moricrase containing ointments has shown 




Enzymes detected in moricrase Modified from (Rudenskaya et al., 2000) 
Protease Mr, kDa 









1.6.1. Moricrase in our study 
 
Moricrase is a rich source of serine protease and the previous research has shown 
evidence of effect of trypsin and trypsin like protease on the activation of protease-
activated receptors in the airways. Workers of crab industries have shown airway 
symptoms including shortening of breath and asthma like symptoms. Moricrase contain 
enzymes which may have effect on the lungs, like trypsin and chymotrypsin. The 
workers at the crab processing area are expected to be exposed to airborne proteases 
(bioaerosols) produced in the crab processing procedure. 
 
 In our study we investigate the specific effect of moricrase on IL-8 levels in A549 cells 
and the activation of protease-activated receptor-2 by using specific siRNA for 





















2.1. General maintenance of cell culture. 
 
2.1.1. Cell medium 
 
Dulbecco's Modified Eagle Medium: Nutrient Mixture F-12 (DMEM/F12) (1:1), 1% 
Glutamine and 10% Fetal Bovine Serum (Gibco, NY, USA) was used to culture the 
cells. The components of the cell medium are: 
 
DMEM/F12: contains a number of  vitamins, cofactors, salts and carbohydrates 
necessary for cell growth support (Even et al., 2006). 
 
L-Glutamine: Glutamine provides support to the growth of cells requiring high energy 
demands and synthesizing large amounts of proteins and nucleic acids. It is an 
alternative energy source for rapidly dividing cells and cells that use glucose 
inefficiently. 
 
FBS: Fetal Bovine Serum (FBS) was used in the medium for all the experiments 
FBS is capable for supporting the growth of a variety of cell types. The availability and 
ease of storage of FBS (Barnes and Sato, 1980) together with its rich content of growth 
factors and low gamma-globulin content in comparison with other animal sera (Shah, 
1999) have led to its adoption as the standard medium supplement. 
 
Phenol red: Most living tissues prosper at a near-neutral pH; that is, a pH near to 7. The 
pH of blood ranges from 7.35 to 7.45, for instance. When cells are grown in tissue 
culture, the medium in which they grow is held close to this physiological pH. Waste 
products produced by dying cells or overgrowth of contaminants cause a change in pH, 
leading to a change in indicator (phenol red) color. For example, a culture of relatively 
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slowly-dividing mammalian cells can be quickly overgrown by bacterial contamination. 
This usually results in an acidification of the medium, turning it yellow. In addition, the 
waste products produced by the mammalian cells themselves will slowly decrease the 
pH, gradually turning the solution orange and then yellow. 
 
2.1.2. Cell culture 
 
The cells kept for stock of culture were not overcrowded in the flask and the medium 
was changed after each 48 hours in order to keep the cells healthy. While the cells used 
in the experiment were counted and approximately exact number of cells incubated for 
the experimental setup. In order to provide in vivo conditions the cells were kept in an 
incubator at 37° C with 5% CO2 in air. 
 
In order to perform good experiments with the cells, regular checking of cell culture 
was needed. Regular checking was to make sure that the cells were showing adherent 
behavior and growing accordingly, if not then a new ampoule was thawn. If there was 
any sign of infection then the flask was removed from the incubator so that infection 
should not spread in other flasks.    
 
2.1.3. Cell counting 
 
Living cells are distinguished from dead cells based upon the integrity of the cell 
membrane. Dead cells allow penetration of water soluble compounds (e.g. Trypan Blue 
0.4%) that cannot cross intact plasma membrane and dead cells lose their cytosolic 
components by diffusion through the compromised membrane and turn blue. The cells 






In this procedure, membrane exclusionary dye, trypan blue 0.4%, was used to count and 
assess cell viability. Viability is given as a percentage of living cells in a cell culture. 
 
 
             Viability =        Number of living cells       X 100      




1. A flask of growing cells were taken out from the stock of cells, 5 ml of cell 
dissociation solution were added in the flask and incubated in a CO2 incubator 
(Maintained 5% CO2 level at 37° C to simulate in vivo conditions) until all cells 
detached and started to float.   
2. After 15 min if the cells were floating then the cells suspension were centrifuged 
for 5 min at 1100 rpm in spin centrifuge. 
3. Supernatant was removed and pellet was dissolved in 1 ml of medium. 
4. 20 µl of cell suspension and 180 µl of trypan blue 0.4% were mixed in a 1.5 ml 
micro tube. 
5. 20 µl of the above mentioned solution was taken out, placed on Burker Chamber 
and the cells were counted. 
6. Number of the cell were counted by using the following formula: 
 
Total number of cells/ml = cells counted in 16 small squires x 10 x 10,000 
(where 10 is dilution factor for trypan blue) 
 








Burker Chamber with cells diluted in Trypan blue 0.4% 
 
Fig.2.1. Method of cell counting at Burker chamber. The cells in the square and which 
are touching the top and left border were counted (О). The cells touching the right 
and lower border were not counted (О).   
Modified from. http://www.fao.org/DOCREP/003/W3732E/w3732e0k.gif 
 
2.1.4. Cell freezing 
 
The freezing method was used to store the cells for longer time. Cells that were 
supposed to be frozen were free from infections with viability over 90%. For A549 cells 






DMEMF/12     4.0 ml 
FBS                 0.5 ml 
DMSO            0.5 ml 





1. A flask of growing cells were taken out from the stock of cells, 5 ml of cell 
dissociation solution were added in the flask and incubated in a CO2 incubator 
(Maintained 5% CO2 level at 37° C to simulate in vivo conditions) until all cells 
started to float.   
2. After 15 min if the cells were floating then the cells suspension were centrifuged 
for 5 min at 1100 rpm in spin centrifuge. 
3. Supernatant was removed and pellet was dissolved in 5 ml of freezing media. 
4. 0.5 ml of cell suspension was aliquot in cryotubes (roughly 500 000 cells/tube) 
and frozen down at -70° C over night and transferred to the liquid nitrogen 
freezer for long term storage. 
 
2.1.5. Cell thawing 
 
A549 cells were thawn at room temperature, not any special equipment is required for 
thawing the cells. Medium (DMEM/F12) was taken to the incubator 15 min prior to 
start of the thawing procedure. The ampoule (cryotubes) was taken out from freezer and 
kept at room temperature in sterile area for 5 minutes to thaw. The cells were mixed 
with 1 ml of medium and centrifuged in a sterile centrifuge tube for 5 min at 1100 rpm.  
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Supernatant was removed and 1 ml of medium was added to dissolve the cell pellet. The 
cells were incubated in a T25 flask in 5 ml of medium (DMEM/F12, 10 % FBS, 1 % of 
Glutamine). The cells were expanded in T75 flask after getting 80-90% confluence. 
The size of T-flask was dependent on the experiment design and number of cells 
needed. Seeding capacity for T25 flask is 1.5 x 106 and T75 flask is 5 x 106. The cell 
medium was changed after each 48 hours in order to get 80-90% confluency. 
 
The cell culture was checked under microscope. If there were no signs of infection and 
cells were in healthy condition then the cells were used for the experiments. In order to 
get good results these observations were followed: 
 
• Healthy growth usually leaves media slightly orange. 
• Too yellow (milky) means bacterial growth. 
• Too purple means low carbon dioxide, cells dead. 
• In order to save time and to get good results the cells were checked daily. In the 
presence of infection (milky yellow colour or any kind of milky appearance) or 
if the cells are not growing then the cells were taken to autoclave and discarded 
and a new ampoule were thawn. 
After thawing, the cells were treated as stock of cells which was used for further 
experiments. 
 
2.2. Growth curve  
 
A549 cells were purchased from American Type Culture Collection (ATCC; no CCL-
185). A growth curve experiment was established to investigate viability and changes in 
behavior of A549 cells. Moreover to demonstrate the growth of A549 cells in our lab 
system and to obtain a population doubling time. A growth curve generally shows: 
 
Lag phase, the time in which cells recover from subculture, attach and spread. 
Log phase, in which the cell number increase exponentially. 





Graph showing the logarithmic cell growth and the plateau stage where the growth 




2.2.1. Doubling time 
 
The doubling time is a time require for cells to double in numbers. Estimated doubling 
time for A549 cell line was 22 hours according to supplier (ATCC). Estimated viability 







Where ln2 is natural log 2. T2 is doubling time and b is slope of increasing number of 
cells in log phase. 
Procedure 
1. A flask of growing cells were taken out from the stock of cells, 5 ml of cell 
dissociation solution were added in the flask and incubated in a CO2 incubator 
until all cells started to float.   
2. After 15 min, if the cells were floating, then the cells suspension were 
centrifuged for 5 min at 1100 rpm in a spin centrifuge. 
3. Supernatant was removed and pellet was dissolved in 1 ml of medium. 
4. 180 µl of trypan blue 0.4% was mixed with 20 µl of cell suspension in a 1.5 ml 
micro tube.  
5. For 12 days 150 000 x 12 = 1 800 000 cells were sufficient to setup the 
experiment.   
6. 5 ml of medium and 150 000 cells were added in each T25 flask and incubated 
in CO2 incubator at 37° C. 
7. For growth curve experiments, the cells were observed for 12 days without 
changing the medium, the dead and live cells were counted after each 24 hours. 
8. The cell population doubling time in the log phase was calculated by the above 
given formula. 
 
2.3. Enzyme activity  
 
Enzyme activity is a measure of the quantity of active enzyme. A stock solution of 
moricrase 5 mg/ml were prepared, by dissolving a solid freeze dried moricrase in dH2O 





2.3.1. Trypsin-like activity 
 
Trypsin is a serine endopeptidase that is formed from trypsinogen in the pancreas. It is 
converted into it’s active form by enteropeptidase in the small intestine. It catalyzes 
hydrolysis of the carboxyl group of either arginine or lysine. 
 
Substrate for trypsin: Nα-Benzoyl-D,L-arginine 4-nitroanilide hydrochloride (DL-
BAPNA, Product number B4875) is a chromogenic substrate for proteolytic enzymes 
such as trypsin, amidase, and balterobin.  
 
Preparation of stock solutions:  
• Stock solution of trypsin was made at the concentration of 1 mg/ml. The 
solution were filtered through sterile filter and frozen down at -20° C for further 
use.  
• Substrate for trypsin was prepared as stock of 100 millimolar DL-BAPNA.70.16 
mg of DL-BAPNA were mixed with 1.6 ml of DMSO and stored at -20° C.  
 
Substrate buffer: 
25 millimolar Tris/HCl, 10 millimolar CaCl2, 2 % (v/v) DMSO, pH 8.1 
1.97g Tris/HCl and 0.687g CaCl2 were dissolved in 300 ml of dH2O. 10 g of DMSO 
were added to the solution and the pH was adjusted to 8.1 by using NaOH final volume 
were adjusted to 500 ml and stored at room temperature. 
 
2.3.2. Chymotrypsin-like activity 
 
Chymotrypsin is a serine endopeptidase secreted by the pancreas as its zymogen, 
(chymotrypsinogen) and carried in the pancreatic juice to the duodenum where it is 
activated by Trypsin. It selectively cleaves aromatic amino acids on the carboxyl side. 
 
Substrate for chymotrypsin: N-Succinyl-Ala-Ala-Pro-Phe-P-Nitroanilide (N-suc-AAPF-
pNA, product number S7388) 
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Substrate buffer:  
0.1M Tris/ HCl, 0.005% Triton X-100, p H 8-8.5 
15.6 g of Tris/ HCl was dissolved in 800 ml of dH2O. 5.3 g of triton x 100 was 
transferred to the Tris/HCl solution; pH was adjusted between 8 to 8.5. Final volume 




1. 5x dilution series were prepared from enzyme stock; dilutions were made in 
substrate buffer 
2. 96-well plate was used and various samples were investigated, 10 µl/ well, and 3 
wells for each dilution.  
3. Substrate solution was added in appropriate wells and optical density was 
measured at 405 nm for 5 minutes (for chymotrypsin-like activity) and 10 
minutes (for trypsin-like activity). 
4. The curve of the measurement has to be below 60°∟ in order to have an 
acceptable limit.  
5. An average of 3 parallels was taken and the enzyme activity was calculated in 
the sample. 
 
Units and calculations for trypsin like activity and chymotrypsin like activity: 
 
1 unit = da/dt x 1/(ε x 1) x 106  x V final 
1 = 0.709 cm (light path) 
V final   = 0.000251  
ε  =  8800 M-1 cm-1 
dA/dt  = mOD/min x 10-3 
1 U = 4.0 x 10-5 x mOD/min 
1U/ml = 4.0 x 10-5 x 1000/10 = 4.0 x 10-3 mOD/min 
Enzyme activity for trypsin like activity and chymotrypsin like activity = Average of 
test sample for each solution × 4.0 × 10-3 
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2.4. Dose Response 
 
 
The science of toxicology as well as pharmacology is based on the principle that there is 
a relationship between a reaction (the response) and the amount of substance received 
(the dose). An important assumption in this relationship is that there is almost always a 
dose below where no response occurs. A second assumption is that once a maximum 
response is reached any further increases in the dose will not result in any increased 
effect (Anonymous, 1993).  
 
Dose response study is a method to determine the relationship between dose of stressor 
and a specific biological response. In this case we use it to evaluate the quantitative 




1. A549 cell culture was expanded until the required number of cells to setup the 
experiment. 
2. The experiments were performed in 24 well plates and the seeding density was 
150 000 cells/well and each well contained 350 µl of medium. 
3. In order to get good results and to avoid any kind of mistakes two parallel 
experiments were performed together. 
4. The medium was changed after 24 hours. 
5. Wells were washed 3 times with serum free medium DMEM/F12 (1:1) on the 
second day, to remove the traces of FBS. After washing three times the cells 
were incubated with DMEM/F12 over night. 
6. On the third day, the cells were stimulated with moricrase.  The following 
concentrations of moricrase were used:  




      0.0166   µg/ml 
      0.03325 µg/ml 
0.0665   µg/ml 
0.137     µg/ml 
0.266     µg/ml 
0.532     µg/ml 
 
7. Tumor necrosis factor (TNF) alpha was used as positive control. 
 
• TNF alpha stock solution was 100 ng/µl. 1:100 dilutions were required so 1 
µl of TNF alpha stock solution were added in 99 µl dH2O. 
• 10µl of the above mentioned solution were added in 1000 µl of serum free 
DMEM/F12 and this solution were used as a positive control. 
 
8. DMEM/F12( without serum) was used as negative control. 
9. Volume/well: 350 µl 
10. Stimulation solutions were kept at 37° C for 15 minutes before adding them to 
the cells. 
11. The medium was removed from the wells and stimulation solution was added. 
12. The wells were incubated for 6 hours. 
13. After 6 hours the morphology of the cells were evaluated under microscope 
and supernatant was frozen down at -20° C for ELISA. 
14. The cells were taken to autoclave and discarded. 
 
2.5. Time response 
 
A study of biological response from a specific biological material at specific time is 
known as time response studies. In the time response studies our best stimulation 
concentration of moricrase (0.03325 µg/ml was used. (Concentration was obtained from 





1. Steps 1-10 (except step 6) were similar to dose response studies. 
2. The medium was removed and 0.03325 µg/ml concentration of moricrase was 
added in all wells. 
3. The wells were incubated for 6, 12, 18, 24 and 48 hours. 
4. After each time period, morphology of the cells was evaluated under microscope 




 The amount of secreted IL-8 in the supernatant was determined by using an ELISA 
(enzyme-linked immunosorbent assay) kit from BD Biosciences, NJ, USA, according to 
the manufacturer's protocol. The absorbance was measured by using an iEMS Multiscan 
EX (Thermo Lab systems). IL-8 production was expressed as pg/ml. 
 
The IL-8 Kit is a solid phase sandwich ELISA. A monoclonal antibody specific for IL-8 
is coated onto the wells of the microtiter strips. Samples, including standards of known 
IL-8 concentrations, control specimens and unknowns were pipetted into these wells.  
 
During the first incubation, the IL-8 antigen and a biotinylated polyclonal antibody 
specific for IL-8 were simultaneously incubated. After washing, the enzyme 
(streptavidin-peroxydase) was added. After incubation and washing to remove the entire 
unbound enzyme, a substrate solution which is acting on the bound enzyme was added 
to induce a coloured reaction product. The intensity of this coloured product was 





(1) ELISA plate is coated with a capture antibody; (2) Sample is added, and the 
respective antigen present binds to capture antibody; (3) Biotin-conjugated secondary 
detection antibody is added, and binds to the antigen captured by the first antibody; (4) 
Streptavidin-HRP is added and binds to the biotin conjugated detection antibody; (5) 
Coloured product is formed in proportion to the amount of antigen present in the 
sample; The reaction is terminated by addition of acid and absorbance is measured at 












Solutions used in ELISA kit and their contents  
Modified from supplier’s protocol 
ELISA Solutions Contents 
 
Detection antibody 30 ml of biotinylated anti-human IL-8 
monoclonal antibody containing FBS and 
ProClin™-150 as preservative 
 
Standard lyophilized recombinant human IL-8 
Enzyme concentrate (250×) 150 μl of 250× concentrated Streptavidin-
horseradish peroxidase conjugate with 
BSA and ProClin™-300 as preservative 
Standard/Sample diluent 30 ml of animal serum with 0.09% sodium 
azide as preservative  
ELISA diluent 12 ml of a buffered protein base with 
0.09% sodium azide as preservative 
Wash concentrate (20×) 100 ml of 20× concentrated detergent 
solution with ProClin™-150 as 
preservative 
TMB substrate reagent 30 ml of 3,3’,5,5’-tetramethylbenzidine 
(TMB) in buffered solution 
Stop solution 13 ml of 1M phosphoric acid 
 
Working detector For a full 96-well plate, 48 μl of Enzyme 








All reagents and samples were brought to room temperature (18 – 25° C) 30 minutes 
prior to use. All standards and samples were run in duplicate. A standard curve was 
prepared in each assay run.   
 
Standards  
• 1 vial lyophilized Standard with required volume (noted on vial label) of 
Standard/Sample Diluent were reconstituted to prepare a 200 pg/ml stock 
standard.  
• In order to make dilutions, 300 μl Standard/Sample Diluent was added to 6 
tubes. Labeled as 100, 50, 25, 12.5, 6.3, and 3.1 pg/ml.  
• Serial dilutions method was used by adding 300 μl of each standard to the next 
tube and vortexing between each transfer. The undiluted standard was used as 
the high standard (200 pg/ml). The Standard/Sample Diluent was used as the 
zero standard (0 pg/ml). 
 
Samples 
• 1: 20 dilutions of all samples (except TNF alpha) were prepared. For TNF alpha, 
1:80 dilutions were prepared. For dilutions “standard/sample Diluent” (provided 
in the ELISA kit) was used.  
 
Wash Buffer 
• 100 ml of wash concentrate were mixed with 1900 ml of distilled water and 2 










1. The required quantity of test strips/wells were removed and placed in well 
holder. 
2. 50 μl of “ELISA Diluent” were pipette into each well.  
3. 100 μl of each standard and sample was pipette into appropriate wells, the wells 
were covered by plate sealers and incubated for 2 hours at room temperature. 
4. Required volume of “Working Detector” was prepared (15 minutes before use) 
according to the instruction manual. 
5. The wells contents were aspirated and washed with 300 μl/well “wash buffer” 
for a total of 5 times. Absorbent paper was used after the last wash to remove 
any residual buffer. 
6. 100 μl of prepared “Working Detector” were added to each well; the wells were 
covered by plate sealer and incubated for next 1 hour at room temperature. 
7. The wells were washed in the same procedure as above but total 7 times. 
8. 100 μl of “TMB One-Step Substrate Reagent” (provided by the supplier) were 
added to each well. The plate were incubated (without Plate Sealer) for 30 
minutes at room temperature in the dark.  
9. 50 μl of “Stop Solution” (provided by the supplier) were added to each well. 
10. Absorbance was measured at 450 and 540 nm within 30 minutes of stopping 
reaction. 
11. Absorbance reading at 540 nm was subtracted from reading of 450 nm. This 







1. The mean absorbance for each set of duplicate standards, controls and samples 
were calculated. The mean zero standard absorbance (i.e. absorbance of diluent) 
was subtracted from each value. 
2. The standard curve on log-log graph paper was plotted, (as shown in Fig. 2.4) 
with IL-8 concentration on the x-axis and absorbance on the y-axis. The best fit 
straight line was drawn through the standard points. 
3. To determine the IL-8 concentration of the samples, the samples’s “mean 
absorbance value” was found out on the y-axis and a horizontal line was drawn 
to the standard curve. At the point of intersection, a vertical line was drawn to 
the x-axis and red the IL-8 concentration. If samples were diluted, the 
interpolated IL-8 concentration was multiplied by the dilution factor. 
 





















Fig. 2.4. Standard curve for the calculation of ELISA results. The standard curve was 
prepared by using the optical density of standard dilutions. Standard curve was plotted 
for every experiment according to the absorbance data of standard solution dilutions. 
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2.7. Small interfering RNA (siRNA) 
 
Small interfering RNA. A mix of three pre-designed siRNAs (Ambion, USA, 
catalogue number 16704, ID nr 1960, 1876, and 1783) for the PAR-2 gene was used.  
The intention was gene silencing or suppression of PAR-2 by using siRNA to study the 
reduction in the production of IL-8 after stimulation. 
 
RNA interference (RNAi) represents a mechanism invented by nature to protect the 
genome. The molecular mechanism of gene silencing provides with small interfering 
RNAs (siRNAs) which allows targeting any gene with high specificity and efficiency.  
 





Fig.2.5 siRNAs as mediator of RNAi and as a tool for gene function analysis. (A) dsRNA 
from various sources is cleaved by the Dicer “multi protein complex” to generate short 
duplexes (siRNAs) or single stranded short RNAs (miRNAs). “Multi protein complexes” 
then are targeted to complementary RNA species to mediate gene silencing. siRNAs 
become part of an “RNA-inducing silencing complex” which mediates gene silencing 
by target RNA cleavage. A related miRNA protein complex is able to silence genes by 
either RNA cleavage or translational inhibition. Both complexes differ by associated 
proteins. (B) This mechanism can be used to analyze gene function in vitro and in vivo. 
Short hairpins generated from vector systems in cells are converted to siRNAs (which 
can also be applied exogenously) thus mediating gene silencing. Modified from 
(Schutze, 2004) 
 
A549 cells (150 000 cells/well) were seeded in 24-well plates and were transfected by 
using Lipofectamine 2000 (Invitrogen). Transfection was performed according to the 
manufacturer's protocol.  
 
Transfection of animal cells typically involves opening transient pores or "holes" in the 
cell membrane, to allow the uptake of siRNA. [http://en.wikipedia.org/wiki/Transfection] 
Lipofectamine 2000 is a cationic liposome formulation that functions by complexing 
with nucleic acid molecules, allowing them to overcome the electrostatic repulsion of 




In order to stimulate A549 cells with moricrase, 5 mg/ml solution of moricrase was 
used as stock. The cells were also stimulated with PAR-2 peptide (4 mg/ml). For 
silencing of receptor; siRNA PAR-2 was used. The Silencer negative control nr 1 
(Ambion, catalogue number 4611) was used as a negative control siRNA   
 
0.03325 µg/ml concentration of moricrase was used for stimulation of A549 cells.  
The receptor of PAR-2 was blocked by using siRNA PAR-2. 
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• 1500 µl of OptiMem (reduced serum medium) was mixed with 30 µl of 
Lipofectamin (Lipofectamin 1 µl/well).                                                
• Incubated for 5 minutes at room temperature. 
• SiRNA-PAR-2: siRNA nr, 1960, 1876, 1783, 50 µl x 12 wells = 600 µl + 600 µl 
Lipofectamin solution were mixed. 
• siRNA negative control, 50 µl x 12 wells = 600 µl + 600 µl Lipofectamin 
solution were mixed together. 
• These Lipofectamin solutions were used as transfection solutions and were made 
20 minutes prior to perform transfection. 
 
1. On the first day 24 well plates were prepared. 150 000 cells/well were seeded 
out with DMEM/F12, 10% FBS, 1% glutamine. Three parallels of each sample 
were used. 
2. The old medium was removed and new medium was added on the second day. 
3. On the third day the old medium was removed and the cells were washed 3x 
with serum free medium. 
4. The above mentioned transfection solution (Lipofectamin) was incubated for 20 
min at room temperature.  
5. 400 µl of OptiMem and 100 µl of transfection solution were added per well. 
6. Transfection solution was added drop by drop while gentle shake of the tray in 
order to get proper mixing. 
7. For completing the transfection procedure, 24 well plates again incubated for 4 
hours. In 5% CO2 incubator at 37° C. 
8. After 4 hours, transfection solution was removed. 
9. Wells were washed and rinsed with 500 µl of serum free medium DMEM/F12. 
New serum free medium was added and incubated over night. 
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10. On the forth day old medium was removed and the wells were washed 3x with 
serum free medium. 
11. Stimulation of transfected  and non-transfected A549 cells with moricrase, 
positive control (PAR-2 peptide (SLIGRL(NH2), and negative control 
DMEM/F12 were taken on the same day (4th day) 












































In order to determine the behavior of A549 cells, a growth curve experiment was 
established. The cell line have shown lag phase, log phase, plateau phase and cell death 
phase. Fig 3.1 (a, b, c) shows that in the first three days (lag phase) the cells were 
sticking to the plastic and adjusting according to the environmental condition, while 
from 3 to 7 days it was a log phase where the cells reproduced exponentially. Day 7 to 
day 8 gives a picture of plateau phase and cells started to degrade after day 8. 
 
The number of dead cells in a culture was increasing day by day, starting from 
approximately 1 and ends almost at 2 million. Maximum number of cells (dead and live 
in a medium) was more than 5 million in each experiment. The calculated mean 
population doubling time for A549 cells in three different experiments was 30.33 ± 2 
(Mean ± Standard Deviation) hours. The growth curve experiment was started with 

























Fig.3.1 (a)  
 
 




















Fig.3.1 (b)        
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Fig.3.1(c)          
 
Fig.3.1 (a, b, c) Growth curve of A549 cell line. A549 cells were seeded out in 12 T25 
flasks in DMEM/F12. Approximately 1.5×105 cells were seeded per flask. Every day 
one flask has been taken for counting the cells. The cells were counted by using 
Burker’s chamber.  
 
In the growth curves blue lines shows the growth of living cells; while the red line 
indicates the number of dead cells. As the days passed the numbers of living cells were 
increased up to the maximum confluence. 4.5×106± 6.5×105 (n=3) living cells were 
present at the day 7.66±0.57 (n=3). Approximately 1 million dead cells were found (in 
all 3 experiments) on the same day. After day 7 the number of living cells reduced in 
the medium while the numbers of dead cells were increased to approximately 2 million 




















A 150 000 4 600 000 7 29.9 
B 150 000 5 200 000 8 28.5 
C 175 000 3 900 000 8 32.6 
Mean ± S.D 1.6×105±1.4×104 4.6×106±6.5×105 7.66±0.57 30.33±2 
Table shows a complete overview of all three growth curve experiments. The table 
shows only the living cells in the culture the dead cells were counted but not shown in 
the Table. 
 
3.2. Activity of PAR-2 stimulating serine 
proteases in Moricrase. 
 
To determine the presence and activity of serine proteases (known PAR-2 stimulators) 



















3.3. Moricrase stimulation of IL-8 production in 
A549 cells 
 
 In order to determine the production of IL-8 after stimulation of A549 cells with 
moricrase, different studies were taken. 
 
3.3.1 Concentration – response studies 
 
 
To explore the concentration response relationship, different concentrations of 
moricrase was used. The cells were stimulated with 0.0166, 0.03325, and 0.0665 µg/ml, 
of moricrase solution. As shown in the Fig. 3.2 (a) The Fig shows that there is a gradual 
increase in the production of IL-8 as the concentration of moricrase is increased. The 
basal (DMEM/F12) production of IL-8 was stable at 200 pg/ml. At 0.0166 µg/ml there 
is only 30% increase in IL-8 production above basal level while at 0.03325 µg/ml it 
increased to 90 % and finally at 0.0665 µg/ml of moricrase the production of IL-8 was 
more than 1.5 times above basal level.  The maximum IL-8 production in this 
experiment was 520 pg/ml at 0.0665 µg/ml while the basal IL-8 level was at 200 pg/ml. 
 
It is also shown in the figure that the production of IL-8 is in increasing mode at 
0.0665 µg/ml which means there may be more increase in IL-8 production with 
increasing concentrations of moricrase. In order to see the maximum response, three 
higher concentrations were used in the next experiment (b) and (c). 
To determine the maximum response of a specific concentration 0.137 µg/ml, 0.266 
µg/ml and 0.532 µg/ml were also used in the experiment as shown in Fig. 3.2 (b). The 
result shows that the concentration 0.0332 µg/ml has produced the maximum IL-8 
(1400 pg/ml) in 6 hours incubation. The basal level (DMEM/F12) was stable at 500 
pg/ml. There was almost two times increase in IL-8 production over basal level at 
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0.03325 µg/ml. The production of IL-8 was decreased (after 0.03325 µg/ml) with 














































  Fig. 3.2 (b)                      
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Fig. 3.2 (c) 
Fig. 3.2. (a, b, c) Effect of different concentrations of moricrase on the secretion of IL-8 
from A549 cells. A549 cells (1.5 × 105 cells/well) were seeded out in DMEM/F12 in 24 
well plates. 24 hours later the medium was changed. After next 24 hours the cells were 
incubated with the indicated concentrations of moricrase. The supernatant was 
harvested 6 hours later and was analyzed for the presence of IL-8 by ELISA. 
 
 
In order to confirm the maximum stimulation concentration, the same dose response 
experiment was setup and it was confirmed that the moricrase stimulates A549 cells and 
give the maximum production of IL-8 at the concentration of 0.03325 µg/ml as shown 
in the Fig.3.2 (c). The maximum production of IL-8 was 3000 pg/ml while the basal 
level was at 360 pg/ml. There was almost 1.5 times more increase in the IL-8 level 
compared to the basal level at the concentration of 0.0166 µg/ml while the production 
of IL-8 compared to 0.03325 µg/ml was decreased in the next higher concentrations 
(0.0665, 0.137, 0.266, and 0.532 µg/ml). The maximum production of IL-8 was more 












Mean ± SD 
Basal Level of IL-8 
(pg/ml) 
200 500 360 353 ± 150.1 
Maximum level of 
IL-8 ( percentage 
above basal level) 





0.0665 0.03325 0.03325 ND 
ND = Not Determined  
 
3.3.1.1. Morphological studies of dose response. 
 
 
To determine the cell behavior after stimulation with different concentrations, 
morphology of the cells were studied in the dose response experiment. We found that 
for 6 hours stimulation of A549 cells with moricrase the cell adherence affected over 
the concentration of 0.0665 µg/ml. We examine under the micro scope (as shown in 
Table 6) that from 0.0166 µg/ml to 0.0665 µg/ml the cells were adherent but they have 
started detachment at 0.137 µg/ml which increased as the concentration increased and 
finally at the concentration of 0.532 µg/ml after 6 hours stimulation the cells were 









of crab cocktail  
(µg/ml) 
Morphology under microscope Time of 
incubation 
in hours 
0.0166 Cells were adherent  6 
0.03325 Cells were adherent 6 
0.0665 10% cells were rounded 6 
0.137 20-25% cells were floating in the medium (detachment) 6 
0.266 More than 50% cells were floating in the medium 6 
0.532 Approximately 90% cells were floating in the medium 6 
 
 
3.3.2. Time-response studies. 
 
 To explore the time-response relationship in IL-8 stimulation by moricrase in A549 
cells, experiments of time response was established. A549 cells were stimulated with 
the best stimulation concentration 0.0332 µg/ml (calculated by dose response) for 6, 12, 
18, 24 and 48 hours.  
 
The results depicted in Fig.3.3 shows that production of IL-8 in A549 cells after 
stimulation with 0.03325 µg/ml of moricrase was increasing as the incubation time 
increased and have shown the maximum production of IL-8 after 24 hours and finally 
reduced after 48 hours.  
 
In the first six hours the production of IL-8 was 55.5% above the basal level. After 18 
hours the percentage production of IL-8 reached to 70% above basal level. Finally the 
maximum stimulation was shown at 24 hours incubation which was 90% above basal 





Fig.3.3 Effect of moricrase stimulation on the secretion of IL-8 from A549 cells in 
different stimulation times.  A549 cells (1.5 × 105 cells/well) were seeded out in 
DMEM/F12, FBS and Glutamine in 24 well plates, the cells were stimulated with the 
concentration of 0.03325 µg/ml and was incubated for 6, 12, 18, 24 and 48 hours. In 
order to give the similar conditions to all samples, six different plates were used. After 
each time period the sample’s supernatant was collected and was analyzed for the 
presence of IL-8 by ELISA.  
 
(■) The drop at 12 hours was probably due to artifact, since this drop was not seen 
in previous or later experiments. This experiment is shown individually and other 
parallel experiments have been omitted due to some technical and contamination 
problems. The x-axis is presented as percentage above basal level as the basal 
levels have also shown increase in IL-8 stimulation. 
 
3.3.2.1.  Morphological studies of time response. 
 
In order to determine the cell behavior after stimulation with 0.03325 µg/ml of 
moricrase at different times, morphological studies were carried out. In our time 
response studies the cells have shown an adherent behavior in the first 18 hours (as 
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shown in Table 7) and have shown less adherence in the next 6 hours (24 hours) and 








Morphology under microscope Concentration 
of crab cocktail 
in µg/ml 
6 The cells were adherent  0.03325 
12 The cells were adherent but approximately 2% of cells 
were rounded 
0.03325 
18 More than 20% cells were rounded 0.03325 
24 Approximately 50% cells were round and 5% were 
floating 
0.03325 
48 Almost 80% cells were floating in the medium 0.03325 
 
3.4. The involvement of protease activated 
receptor-2 on production of IL-8 
 
3.4.1. PAR-2 peptide induces the secretion of IL-8 in A549 cells. 
  
To determine whether PAR-2 activation could enhance the secretion of IL-8 in human 
airway epithelial cells, A549 cells were stimulated with a known agonist of PAR-2 
(PAR-2 peptide SLIGRL-NH2). Previous studies have shown that A549 cell line 
expresses the PAR-2 (Bohm et al., 1996; Asokananthan et al., 2002a) and human PAR-




To find out the increase in the production of IL-8 compared to untreated cells, 
“untreated cells” (write side) were stimulated with serum free medium while “SLIGRL-
NH2” (left side) were stimulated with PAR-2 peptide. In our study we have seen that the 
cells stimulated by PAR-2 peptide have shown more than 5 times more production of 
IL-8 compared to untreated cells as shown in the Fig. 3.4.  
 















Fig.3.4 Effect of PAR-2 stimulation on the secretion of IL-8 in A549 cells. A549 cells 
(1.5 × 105 cells/well ) were seeded out in 24 well plates. On the next day the medium 
was changed. On the following day the cells were incubated in a serum free medium 
over a night. On the following day the cells were stimulated with PAR-2 peptide 
(SLIGRL-NH2). The supernatant was harvested 6 hours later and was analyzed for the 
presence of IL-8 by ELISA. Data are expressed as mean±SD,( n = 3). 
 
3.4.2. Effect of transfection of A549 cells on the production of IL-8 
 
In order to determine the effect of transfection on production of IL-8, A549 cells were 
transfected with siRNA silencer (negative control) and then stimulated with PAR-2 
peptide as shown in the Fig. 3.5. After transfection of A549 cells with negative control 
there was 17.5% reduction in the production of IL-8 compared to non transfected cells 
































Fig.3.5 Effect of transfection of A549 cells against PAR-2 peptide on the production of 
IL-8. A549 cells were seeded in DMEM/F12 in 24 well plates. 48 hour later the cells 
were transfected with siRNA negative control. Non-transfected, transfected and 
untreated cells were kept in serum free standard  medium for 24 hours until the 
stimulation by PAR-2 peptide.  6 hours later the supernatant was harvested and was 
analyzed for the presence of IL-8 by ELISA. Data expressed as mean ± SD,( n = 3). 
 
 
3.4.3. PAR-2 involvement on the production of IL-8 by Moricrase 
stimulation. 
 
To determine if moricrase induced IL-8 secretion in the A549 cells through activation 
of PAR-2, we have used a combination of the three siRNAs to knock down the 
expression of the PAR-2. As shown in the Fig. 3.6 there is 85.5% reduction in the 
production of IL-8 in PAR-2-siRNA transfected cells, compared to the cells transfected 
by the siRNA silencer (negative control). The amount of IL-8 production in PAR-2-
siRNA transfected cells was 8.8% above basal level while the amount of IL-8 produced 

































Fig.3.6 Inhibition of IL-8 secretion from A549 cells using siRNA against PAR-2. A549 
cells (1.5 × 105 cells/well) were seeded out in DMEM/F12, FBS and Glutamine in 24 
well trays. Forty eight hours later the cells were transfected with a mixture of three 
different siRNAs targeting PAR-2 and with siRNA negative control. Cells were kept in 
serum free medium for 24 hours until stimulation with moricrase. The supernatant was 
harvested six hours later and was analyzed for the presence of IL-8 by ELISA. Data 
expressed as mean ± SD, (n = 2).  
 
3.4.4. Comparison of moricrase and spotted mackerel trypsin in 
stimulation of A549 cells and IL-8. 
 
To determine the effect of spotted mackerel trypsin stimulation and production of IL-8 
by A549 cells a comparison study have been performed with moricrase and spotted 
mackerel. A549 cells were stimulated with 0.01 mU/ml of spotted mackerel trypsin and 
0.03325 µg/ml of moricrase as shown in the Fig. 3.7. The results have shown more than 
6 times increase in the production of IL-8 by spotted mackerel trypsin in comparison 
with moricrase. The basal level shows non stimulated cells.  
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Fig.3.7 Comparison between stimulation of A549 cells by moricrase and by spotted 
mackerel. A549 cells were seeded in DMEM/F12 in two different 24 well trays. 24 hour 
later the fresh medium were given to the cells after next 24 hours the cells were washed 
3 times with DMEM/F12 and incubated over a night. The next day after the cells were 
stimulated with 0.03325 µg/ml of moricrase and 0.01mU/ml of spotted mackerel 
trypsin. 6 hours later the supernatant was harvested and was analyzed for the presence 
of IL-8 by ELISA. Data expressed as mean ± SD, (n = 3). 
 
3.4.5. Comparison of moricrase and spotted mackerel trypsin in 
inhibition of IL-8 stimulation by PAR-2 siRNA. 
 
In order to compare the effect of siRNA PAR-2 on the production of IL-8 in moricrase 
and in spotted mackerel trypsin these studies were carried out as shown in the Fig. 3.8. 
Spotted mackerel trypsin at the concentration of 0.01 mU/ml was able to produce 
approximately 10 times more stimulation of IL-8, compared to 0.03325 µg/ml of 





Inhibition of IL-8 by PAR-2 siRNA in moricrase 






























Fig.3.8 Inhibition of IL-8 production by siRNA PAR-2 in moricrase and spotted 
mackerel. A549 cells (1.5 × 105 cells/well) were seeded out in DMEM/F12 in 24 well 
plates. 48 hours later the cells were transfected with a mixture of three different siRNAs 
targeting PAR-2 and with siRNA negative control. Cells were kept in serum free 
medium for 24 hours until stimulation with moricrase and spotted mackerel. The 
supernatant was harvested six hours later and was analyzed for the presence of IL-8 by 


















4.1. Usage of A549 cells in our experiments 
 
A549 cells are human lung adenocarcinoma cells. A549 cells are not fully representative 
of normal human respiratory epithelium but have been a useful in vitro model to study 
human pulmonary epithelium (Wong et al., 1998). A549 cell line has many 
characteristics in common with the human type II lung epithelial cells. The A549 cell 
line produces IL-8 after stimulation with a different variety of biological and chemical 
agents (Hansen, 1997; Van Wetering et al., 1997; Palmberg et al., 1998). These cells 
were used in all the experiments. A549 cells in our laboratory has shown clear response 
regarding production of IL-8 and these cells are highly sensitive against stimulation. 
 
The cell culture of A549 was established in 1972. Growth curve experiments as shown 
in Fig 3.1 (a, b, c) has followed the common growth curve behavior in our laboratory. 
Our growth curve experiment data depicted that the cell line behavior was not similar in 
all the experiments although A549 cell line is one of the well established model system. 
In the cultured cells, in general there may be a gradual change in the behavior that 
might be due to some small differences in growth conditions like media, supplements, 
antibiotics, temperature etc. that may favor a certain sub population of the cell line. 
 
The documented doubling time provided by the supplier was 22 hours but in our lab 
experiments the mean doubling time was 30.33 hours. That might be due to favorable 
growth of subclasses generated by many replications. Doubling time up to 25 hours has 
been reported previously (Viale et al., 2008). This reflects that the cell line is not 
showing the exact behavior all the time it might be due to some handling deficiencies 
but all the experiments were tried to be performed in the same conditions. 
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4.2. Moricrase as a stimulator of IL-8 levels in A549 cells. 
 
 
The production of  IL-8 at basal level (in a plane medium) increases gradually as the 
previous studies shows that A549 cell line produces IL-8 by itself in a time dependent 
manner (Arenberg et al., 1996). There is only 58% increase in the production of IL-8 
above basal level after six hours which leads to 70% increase in the production of IL-8 
after 18 hours. The maximum production of IL-8 have been seen after 24 hours 
incubation, while after 48 hours the basal level of IL-8 was equal to the stimulation 
levels of IL-8 which shows exactly the same behavior as mentioned above that the cells 
produce IL-8 in the plane medium. 
 
The moricrase concentration of  0.03325 µg/ml has shown maximum response while 
higher concentrations were not been able to produce better responses. Instead of 
moricrase other known stimulators of A549 cells like trypsin, have shown higher levels 
of IL-8 from A549 cells after 24 hours incubation (Sachse et al., 2006). Endotoxins 
derived from P.Aeruginosa, produced more than 6000 pg/ml of IL-8 in A549 cells after 
24 hours incubation in a dose dependent manner (Hansen et al., 1999).   
 
A possible reason for low stimulation of IL-8 by higher concentrations of moricrase 
might be due to internalization of PAR-2. The higher concentrations of moricrase might 
induce internalization or desensitization of PAR-2 by independent phosphorylation of 
the receptor at intracellular tail. 
 
Morphological studies have shown the cell behavior after stimulation with different 
concentrations of moricrase which showed us that the higher concentrations of 
moricrase can cause detachment of the cells. We have studied the effect of trypsin on 
A549 cells and previous studies shows that trypsin is a power full cell dissociating agent 
and we have examined that the higher concentrations of moricrase leaded to cell 
detachment which may be the effect of trypsin.  
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Our results confirm that moricrase is a stimulator of IL-8 in A549 cells but has shown a 
difference in the stimulation compared to the known stimulators (trypsin, endotoxins). 
In short, we have an effective model system of cell responding to moricrase by IL-8 
stimulation. In our three parallel experiments the difference between productions of IL-
8 can be due to: 
• The cell concentration. The cells were counted on Burker chamber as there is not 
any exact method of  counting such a large number of cells. It was assumed that the 
number of cells were 150,000 per well by making the dilution of calculated cell 
suspension.  
• Differences in the cell treatment. If the cells were less confluent before seeding or 
in low healthy condition they may need longer time to get in logarithmic cell growth 
and to produce maximum response to stimulation. 
 
 
4.3. Possible consequences of IL-8 stimulation in vivo 
 
IL-8 is an indicator of innate pulmonary inflammation; many studies have shown that 
A549 cells have the potential to produce IL-8 after stimulation (Hansen, 1997). The 
results have shown that moricrase is able to stimulate the production of IL-8 from A549 
cells in our model system although it is difficult to compare in vitro results directly with 
in vivo situation. However if we study the similarities happening in vivo, this could 
mean that: 
• Hepatopancreatic enzymes from king crab may promote inflammation, if 
inhaled in a significant quantity at the king crab industry. 
• Pharmaceutical usage of moricrase may be less applicable if inflammatory 







4.4. Induction of IL-8 by PAR-2 peptide. 
 
SLIGRL-NH2 is a known PAR-2 peptide which stimulates PAR-2 in A549 cells and 
produces the response. Fig. 3.4 showed the comparison between the responses of A549 
untreated cells (plane medium) and A549 cells treated with PAR-2 peptide. It confirmed 
that PAR-2 peptide was stimulating A549 cells while the difference between untreated 
cells and the cells stimulated by PAR-2 peptide was more than 5 times as PAR-2 
peptide has shown 1480 pg/ml production of IL-8 while untreated cells have shown 
only 243.3 pg/ml production of IL-8. This experiment has also confirmed that 
unstimulated cells (basal level) were also producing IL-8. 
 
 
4.5. Effect of transfection on production of IL-8 levels 
 
We have used a method of transfection in order to observe the involvement of PAR-2. 
As shown in Fig 3.5 that transfection by itself, also effects on the production of IL-8. 
We have seen 17.5% reduction in transfected cells compared to non-transfected cells 
while both (transfected and non-transfected) cells were stimulated with PAR-2 peptide.  
 
siRNA negative is a negative control with sequences that do not target any gene 
product. This substance is essential for determining siRNA transfection efficiency and 
to control for the effects of siRNA delivery. In order to be more precise about the 
experiments all results were compared with siRNA negative (negative control) instead 




4.6. Involvement of Protease Activated Receptors in moricrase 
stimulation of IL-8 
 
In A549 cells activation of PAR-2 induces release of IL-6 and IL-8 (Asokananthan et 
al., 2002a). In the respiratory system PAR-2 is mainly considered as pro-inflammatory 
(Knight et al., 2001). Previous research shows that production of IL-8 from A549 cells 
by salmon trypsin (Larsen et al., 2008) and by dust mites (Asokananthan et al., 2002b) 
is PAR-2 mediated. 
We examined the involvement of PAR-2 in the production of IL-8 by stimulating the 
cells with moricrase as shown in the fig. 3.6. Moricrase has shown 85.5% reduction in 
the production of IL-8 after treating with combination of three specific siRNA as 
compared to the cells transfected with siRNA negative (negative control). This 
experiment confirmed the involvement of PAR-2 in the production of IL-8 by 
moricrase. Lower stimulation levels of IL-8 by moricrase might be due to: 
 
• The involvement of any other pathway for IL-8 stimulation; 
• The transfection by PAR-2 siRNA is incomplete; 




4.7. Comparison of moricrase and spotted mackerel trypsin in 
stimulation of A549 cells and IL-8. 
 
 
Spotted mackerel trypsin is a known stimulator of PAR-2 and produces IL-8 in a PAR-2 
dependent pathway (A. Larsen-personal communication). Reason for comparing spotted 
mackerel with moricrase was to understand the difference in the production of IL-8 
after stimulating A549 cells with a pure trypsin and a mixture of proteases. In moricrase 
there is not only trypsin which affects the IL-8 levels as other proteases may also 
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produce effects. Elastase is one of the proteases present in moricrase and might be able 
to produce disarming effect in the receptor, preventing activation by trypsin (Dulon et 
al., 2003). Trypsin is taking part in the stimulation but other proteases may also produce 
effect. So elastase and possibly other enzymes (present in moricrase), (Rudenskaya et 
al., 2000) might cleave the amino terminal exodomain of PAR-2 downstream at trypsin 
cleavage/activation site thus preventing the attachment of trypsin  to the receptor and 
blocking the stimulation.  
 
The result of Fig. 3.8. have shown that in spotted mackerel the difference between 
production of IL-8 by PAR-2 siRNA transfected cells (red bar) and siRNA negative 
(negative control) transfected cells (blue bar) is only 60.35% while at the same 
condition moricrase has shown 85.5% difference in both transfected cells. This shows 
that moricrase is showing the involvement of PAR-2 but is not been able to produce 




We have seen a sudden drop in the production of IL-8 in the time response experiment 
after 12 hours (red dot in Fig 3.3) it shows that after 12 hours the stimulation in basal 
level was equal to the stimulation by moricrase as the samples were stimulated in 
parallel wells it might be possible that in the 12 hours wells any unseen contamination 
or infection was generated which cannot be jugged under microscope because in the 
same plate all other samples were present and not any problem was seen in any other 
sample so it means media and our incubator conditions were fine.  
 
The time response experiment was performed total 5 times but each time we have seen 
some infections problem that can be due to; 
• Absence of antibiotic in our media 
• Any bacterial or fungal growth in the incubator   
• The presence of infectious substance in micropipette etc.  
 66
Several reasons can be generated for infections problems because with the same 
materials in 6 hours incubation we have not seen any infection. To investigate the 
infection in our cell line, mycoplasma test was performed (data not shown) and the 
results have not shown any signs of infection in the cell line. The infections were also 
checked under microscope every time before performing the experiments and were not 



































Moricrase has the ability to produce an inflammatory reaction in human pulmonary 
epithelial cells via stimulation of interlukin-8 (IL-8). This production of IL-8 was 
mediated through PAR-2 pathway. Stimulation of IL-8 by moricrase is time and 
concentration dependent. Concentrations of moricrase higher than 0.03325 µg/ml 
reduces the IL-8 stimulation. Spotted mackerel trypsin is a better stimulator of IL-8 as 
compared to moricrase. Moricrase is a mixture of enzymes including trypsin, further 
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